C9079 – Injection, evinacumab-dgnb, 5 mg

Long description

Injection, evinacumab-dgnb, 5 mg

Short description

Inj, evinacumab-dgnb, 5 mg

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Added

July 1, 2021

Last change

October 1, 2021 – No change

Termination date

September 30, 2021

Nearby C codes

• C9071 – Injection, viltolarsen, 10 mg
• C9072 – Injection, immune globulin (asceniv), 500 mg
• C9073 – Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9074 – Injection, lumasiran, 0.5 mg
• C9075 – Injection, casimersen, 10 mg
• C9076 – Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9077 – Injection, cabotegravir and rilpivirine, 2mg/3mg
• C9078 – Injection, trilaciclib, 1 mg
• C9080 – Injection, melphalan flufenamide hydrochloride, 1 mg
• C9081 – Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9082 – Injection, dostarlimab-gxly, 100 mg
• C9083 – Injection, amivantamab-vmjw, 10 mg
• C9084 – Injection, loncastuximab tesirine-lpyl, 0.1 mg
• C9085 – Injection, avalglucosidase alfa-ngpt, 4 mg
• C9086 – Injection, anifrolumab-fnia, 1 mg
• C9087 – Injection, cyclophosphamide, (auromedics), 10 mg